Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Natus welcomes Optima Medical to the Natus family of solutions
Private Equity | Healthcare

Natus welcomes Optima Medical to the Natus family of solutions

The shareholders of Optima Medical Limited have sold the company to Natus Medical Incorporated.

Learn more
Westminster Homecare has been acquired by Care at Home
Healthcare

Westminster Homecare has been acquired by Care at Home

The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.

Learn more
The MOLE Clinic Limited has been acquired by Sk:n (backed by TriSpan)
Private Equity | Healthcare

The MOLE Clinic Limited has been acquired by Sk:n (backed by TriSpan)

The shareholders of The MOLE Clinic Limited have sold the company to Sk:n.

Learn more
“Having known the Oaklins Evelyn Partners team for many years, we chose to work with them because they have a strong track record in healthcare and understood our business. We were delighted with our choice as the team rolled up their sleeves, anticipating and meeting challenges along the way. This “can-do” attitude was key in finding the right party and achieving a deal that met our needs.”

Sushil Radia

CEO, Westminster Homecare Ltd.

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=XEP&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Belgian radioisotope producer secures US$104.1 million to expand global production

DEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

Learn more

Talk to our local specialists

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital